Thursday, February 27, 2025
spot_img

Ardelyx to Participate in Upcoming Investor Conferences

WALTHAM, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced its participation in the following upcoming investor conferences:

Leerink Partners 2025 Global Healthcare Conference
Location: Miami, FL
Presentation: Tuesday, March 11 at 8:00 a.m. ET
1×1 Meetings: Tuesday, March 11

To access the live webcast of the Leerink presentation, please visit the Events and Presentations page within the Ardelyx website at ir.ardelyx.com. A replay of the presentation will be available on the Ardelyx website for 30 days following the event.

Jefferies Biotech on the Beach Summit
Location: Miami, FL
1×1 Meetings: Wednesday, March 12

Barclays 27th Annual Global Healthcare Conference
Location: Miami, FL
Fireside Chat: Thursday, March 13 at 10:00 a.m. ET
1×1 Meetings: Thursday, March 13

To access the live webcast of the Barclays Fireside Chat, please visit the Events and Presentations page within the Ardelyx website at ir.ardelyx.com. A replay of the fireside chat will be available on the Ardelyx website for 30 days following the event.

About Ardelyx, Inc.
Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been submitted in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. For more information, please visit https://ardelyx.com/ and connect with us on X (formerly known as Twitter), LinkedIn and Facebook.

Investor and Media Contacts:
Caitlin Lowie
[email protected]

Powered by SlickText.com

Hot this week

Tintina Announces Appointment of Interim CEO

TORONTO, Feb. 26, 2025 (GLOBE NEWSWIRE) --...

SJW Group Announces 2024 Financial Results

2024 reported diluted EPS of $2.87 and adjusted diluted...

ThreeD Capital Inc. Releases Results for the Three and Six Months Ended December 31, 2024

TORONTO, Feb. 26, 2025 (GLOBE NEWSWIRE) --...

Gogo to Report Fourth Quarter and Full Year 2024 Results on March 14, 2025

BROOMFIELD, Colo., Feb. 26, 2025 (GLOBE NEWSWIRE)...

Postal Realty Trust, Inc. Reports Fourth Quarter and Year End 2024 Results

- Introduces 2025 AFFO Guidance of $1.20 to $1.22...

Topics

spot_img

Related Articles

Popular Categories

spot_img